Figure 2.
Genetic-risk-adjusted cumulative incidence curves for PHS290. Curves are shown for the upper 5th (>95th) and upper 20th (>80th) percentile of PHS290 for clinically significant and non-clinically-significant prostate cancer. The reference curves represent the overall population average from the UK.